Focus Partners Advisor Solutions’s ARK Genomic Revolution ETF ARKG Stock Holding History

Focus Partners Advisor Solutions’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$215K	Buy	+3,960	New	+$178K	﹤0.01%	1258

Other funds holding ARKG

Jefferies Financial Group New York $13.5B AUM 36.68% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Florin Court Capital London, United Kingdom $97M AUM 40.08% 1-Year Est. Return

NTV Asset Management Charleston, West Virginia $1.08B AUM 23.94% 1-Year Est. Return

Midwest Financial Partners Investments St. Cloud, Minnesota $260M AUM 10.89% 1-Year Est. Return

Canal Insurance Company Greenville, South Carolina $426M AUM 30.47% 1-Year Est. Return

Gimbal Financial Carmel, Indiana $172M AUM

HighTower Advisors Chicago, Illinois $106B AUM 21.33% 1-Year Est. Return

Focus Partners Advisor Solutions's ARKG Position: Q3 2026 in Review

Focus Partners Advisor Solutions opened a new position in ARK Genomic Revolution ETF (ARKG) in Q3 2026: 3,960 shares worth $215K. The stake represents ﹤0.01% of the portfolio and ranks #1258 among its holdings.

191 funds tracked by Wall St. Rank hold ARKG as of Q3 2026.

Focus Partners Advisor Solutions held 3,960 shares of ARK Genomic Revolution ETF worth $215K as of Q3 2026.
ARK Genomic Revolution ETF was a new Focus Partners Advisor Solutions position in Q3 2026.
ARK Genomic Revolution ETF made up ﹤0.01% of Focus Partners Advisor Solutions's portfolio in Q3 2026, its #1258 holding.
191 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2026.

Based on Focus Partners Advisor Solutions's 13F filing for Q3 2026, filed 10 Nov 2026.